[Therapeutic use of tiapride in movement disorders]
[Article in
French]
- PMID: 211595
Item in Clipboard
[Therapeutic use of tiapride in movement disorders]
[Article in
French]
Sem Hop.
1978 May.
Abstract
Tiapridal was given to twenty-four patients suffering from dyskinesias. Therapeutic efficacity seems to the etiology. Not any fonctitonal improvement was observed in parkinsonism with dyskinesia consecutive to Dopa therapy. On the other hand a good efficacity was found in the treatment of choreas with a quite good tolerance; the functional result will depend of the evolutive state of the disease.
Similar articles
-
Involuntary movement disorders.Neurol Clin. 1984 Feb;2(1):71-89. Neurol Clin. 1984. PMID: 6239089 Review.
-
[Therapeutical approach to involuntary movements (author's transl)].Sem Hop. 1979 Feb 8-15;55(5-6):262-4. Sem Hop. 1979. PMID: 219537 French.
-
[Tiapride in persistent dyskinesias following long-term L-dopa for parkinsonism].Harefuah. 1985 Mar 1;108(5):227-9. Harefuah. 1985. PMID: 4007677 Hebrew. No abstract available.
-
[Clinical trial of tiapride in patients with dyskinesia (author's transl)].Sem Hop. 1982 Mar 25;58(12):725-33. Sem Hop. 1982. PMID: 6283645 Clinical Trial. French.
-
[Duality of dopaminergic receptors. Pharmacologic and clinical perspectives].Sem Hop. 1978 May;54(13-16):563-7. Sem Hop. 1978. PMID: 211603 Review. French.
Cited by
-
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-96. doi: 10.1007/s00787-011-0163-7. Eur Child Adolesc Psychiatry. 2011. PMID: 21445724 Free PMC article.
-
The Many Faces of Huntington's Chorea Treatment: The Impact of Sudden Withdrawal of Tiapride after 40 Years of Use and a Systematic Review.J Pers Med. 2022 Apr 6;12(4):589. doi: 10.3390/jpm12040589. J Pers Med. 2022. PMID: 35455705 Free PMC article. Review.